Metabolic Disorders Completed Phase 3 Trials for Losartan (DB00678)

Also known as: Metabolic Disorder / Metabolic disorder, unspecified / Metabolic disorder NOS / Generalized metabolic disorder (disorder) / Unspecified disorder of metabolism / Metabolic disease (disorder) / Metabolic Diseases

IndicationStatusPhase
DBCOND0035995 (Metabolic Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00546052
A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)Treatment